Response by Herrmann et al to Letter Regarding Article, "Vascular Toxicities of Cancer Therapies: The Old and the New-An Evolving Avenue"

Circulation. 2016 Nov 15;134(20):e466-e467. doi: 10.1161/CIRCULATIONAHA.116.024415.

Authors

Joerg Herrmann¹, Eric H Yang¹, Cezar Iliescu¹, Konstantinos Marmagkiolis¹

Affiliation

¹ From Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic Rochester, MN (J.H.); Division of Cardiology, University of California at Los Angeles (E.H.Y.); University of Texas, MD Anderson Cancer Center, Houston (C.I.); Citizens Memorial Hospital, Bolivar, MO (K.M.); and University of Missouri, Columbia (K.M.).

PMID: 27881502
DOI: 10.1161/CIRCULATIONAHA.116.024415

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents / adverse effects*
Cardiovascular System / drug effects*
Humans
Neoplasms / drug therapy*

Substances

Antineoplastic Agents